GELS MEXC RealStocks
Own real GELS shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-14 19:47:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Gelteq Limited (GELS) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.40, with a market capitalization of $4.08M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.37 to $2.01. This page covers its latest market performance, valuation, price trends and company information.
$4.08M | |
$0.38 | |
$0.41 | |
$0.37 | |
$0.38 | |
13.03K | |
2.90M | |
-- | |
$2.01 | |
$0.37 | |
-- | |
-- |
Gelteq Limited (GELS) last closed at $0.40 as of 2026-11-13 23:20:00, up 3.92% ($0.01) from the previous close of $0.38.
During the latest regular trading session, GELS traded between $0.37 and $0.41, with a volume of 13.03K shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, Gelteq Limited (GELS) moved from $0.46 to $0.40, representing a decline of 13.30% ($0.06).
The stock traded between $0.37 and $0.47 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 27.10 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1.8%
GELS is currently trading at $0.40, placing it 1.8% of the way from its 52-week low of $0.37 to its 52-week high of $2.01. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
| Employees | 8 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Gelteq Limited (GELS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to GELS, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between GELS shares and USD.
GELS Shares to USD
1.00 GELS shares = 0.395 USD
Calculations are estimates based on the latest available price and are for reference only.